Encyclopedia of Pharmaceutical Science and Technology, (6 volumes set) - 4th Ed (4^th Ed.)

Pharmaceutical science deals with the whole spectrum of drug development from start to finish. There are many different facets to the pharmaceutical industry, from initial research to the finished product, including the equipment used, trials performed, and regulations that must be followed. Presenting an overview of all of these different aspects, the Encyclopedia of Pharmaceutical Science and Technology, Fourth Edition is a must-have reference guide for all laboratories and libraries in the pharmaceutical field. Bringing together leaders from every specialty related to pharmaceutical science and technology, this is the single-source reference at the forefront of pharmaceutical R&D.

The strength of this work is not only its breadth but also the caliber of contributing writers, all experts in their field, writing on all aspects of pharmaceutical science and technology. The fourth edition offers 29 new chapters ranging from biomarkers, computational chemistry, and contamination control to high-throughput screening, orally disintegrating tablets, and quality by design. The encyclopedia details best practices of equipment used, methods for manufacturing, options for packaging, and routes for drug delivery. The volumes also provide a thorough understanding of the choices behind each method. In addition, the regulations, safety aspects, patent guidance, and methods of analysis are presented.

Key Areas Covered:

• Analytics
• Biomarkers
• Dosage forms
• Drug delivery
• Formulation
• Informatics
• Manufacturing
• Packaging
• Processing
• Regulatory affairs
• Systems validation

This is an authoritative reference source for those practicing in any area of pharmaceutical science and technology, enabling the pharmaceutical specialist and novice alike to keep abreast of developments in this constantly evolving and highly competitive field.

Also Available Online
This Taylor & Francis encyclopedia is also available through online subscription, offering a variety of extra benefits for researchers, students, and librarians, including:

• Citation tracking and alerts
• Active reference linking
• Saved searches and marked lists
• HTML and PDF format options

Contact Taylor and Francis for more information or to inquire about subscription options and print/online combination packages.
US: (Tel) 1.888.318.2367; (E-mail) e-reference@taylorandfrancis.com
International: (Tel) +44 (0) 20 7017 6062; (E-mail) online.sales@tandf.co.uk

29 New Chapter Topics:

Automated Dissolution Testing

Biomarkers in Drug Discovery and Development

Computational Chemistry

Contamination Control: Cleanrooms and Clean Air Devices

Control of genotoxic impurities in pharmaceutical products

Crystal Form Analysis of Active Pharmaceutical Ingredients (APIs)

Drug Delivery using Electrophoresis

Drug Delivery: Inner Ear

Drug Transporters in ADME

Evolutionary Computing and Formulation Optimization

Freeze Drying of Biologicals

Good Publication Practice

High-Throughput Screening (HTS) in Drug Discovery

Impurity Identification in Pharmaceuticals

Injection Molding and its Drug Delivery Applications

Microcalorimetry in Pharmaceutical Development

Multivariate Statistical Analysis

Nano-Needle Systems for Vaccine Delivery

Oral Lipid-Based Formulations

Orally Disintegrating Tablets

Parenteral Formulation: Local Injection Site Reaction and Muscle Tolerance

Particle Shape Analysis

Proteins and Peptides: Physical and Chemical Stability

Quality by Design (QbD) and Analytical Method Development

Quality Target Product Profile (QTPP) for Pharmaceutical Packaging and Delivery Systems

Quality by Design (QbD) in Freeze Drying

Scale-Up of Solid Dispersions

Single-Use Processing in the Pharmaceutical Industry

Statistical Outliers: Methods and Applications

James Swarbrick, D.Sc., Ph.D., is the president of PharmaceuTech, Inc., Pinehurst, North Carolina, USA. He has served in a number of industrial and academic positions, including director of product development at Sterling-Winthrop Research Institute, Rensselaer, New York, and vice president for research and development and vice president for scientific affairs at AAIPharma, Wilmington, North Carolina, USA. Prior to joining AAIPharma, he was a professor and chairman of the Division of Pharmaceutics at the University of North Carolina at Chapel Hill School of Pharmacy.

Dr. Swarbrick is a Fellow of the American Association of Pharmaceutical Sciences, the Royal Society of Chemistry, and the Royal Pharmaceutical Society of Great Britain. He has also served as a member and chairman of the FDA’s Generic Drugs Advisory Committee, as chairman of the PhRMA Foundation’s Pharmaceutics Advisory Committee, as well as a member of the PhRMA Foundation’s Scientific Advisory Committee.